Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
Go back to Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio| (NASDAQ: IMDX) | Delayed: 3.95 +0.37 (10.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $ | |||
| Open | $3.67 | 52 Week Low | $ | |||
| Day High | $3.98 | P/E | N/A | |||
| Day Low | $3.51 | EPS | $ | |||
| Volume | 197,737 | |||||

